Skip to content
ppharmaranks
Menu

Best treatments for tourette syndrome

14 products may treat tourette syndrome, spanning FDA drug classes such as central alpha-2 adrenergic agonist, atypical antipsychotic, typical antipsychotic. The current highest-rated option is clonidine hydrochloride. Ranked below by our independent recall-safety rating (rated where FDA data exists) — not medical advice; always consult a professional.

Quick answer: Of the 14 drugs we list for tourette syndrome, all are available as lower-cost generics, spanning classes such as central alpha-2 adrenergic agonist, atypical antipsychotic, typical antipsychotic. They’re ranked by each drug’s FDA recall-safety record — not clinical effectiveness for tourette syndrome — so confirm the right choice with your prescriber.

Rated against independent regulatory sources·Last updated August 20, 2026·How we rate

Understanding tourette syndrome

"Tourette syndrome" is a narrower label than most people who land here assume. StatPearls (NCBI Bookshelf) sets out the DSM-5 criteria: "Multiple motor tics and one or more vocal tics have been present at some time during the illness, although not necessarily concurrently," the tics "may wax and wane in frequency but have persisted for more than 1 year since the onset of the first tic," and "Onset is before age 18." Only one kind of tic, and the diagnosis is persistent (chronic) motor or vocal tic disorder; under a year, and it is provisional tic disorder — different names, same clinic. The swearing the name is famous for is the exception, not the rule: StatPearls states coprolalia "affects less than 10% of patients with GTS." What patients actually report is a premonitory urge — "a vague sense that they need to perform the movement, followed by a sense of relief after the tic" — and tics can usually be held back, though "this active suppression can take a tremendous amount of focus and energy," and StatPearls adds that suppressing tics "causes the premonitory urge to build to a level that can be quite distressing." StatPearls puts prevalence at up to 1 percent of the population, with typical tic onset at 4 to 6 years and "symptoms peaking around 10 to 12 years of age." MedlinePlus (NLM) adds that tics "usually start in childhood and may be worst in the early teens" and that "many people eventually outgrow them." This is general information, not medical advice.

First-line treatment

MedlinePlus (NLM) states plainly that "No treatment is needed unless the tics interfere with everyday life" — impairment, not the diagnosis itself, drives the decision. When treatment is warranted, the 2019 American Academy of Neurology practice guideline on the treatment of tics puts behavioral therapy ahead of drugs: "For people with tics who have access to CBIT, clinicians should offer CBIT as an initial treatment option relative to medication" (Level B). Where ADHD co-occurs, the AAN says physicians "should counsel individuals with tics and comorbid ADHD that α2 adrenergic agonists may provide benefit for both conditions" (Level B). Antipsychotics are a weaker recommendation — physicians "may prescribe" them when benefits outweigh risks (Level C) — and the AAN attaches duties to them: monitor for drug-induced movement disorders (Level B), and counsel patients on antipsychotics' "extrapyramidal, hormonal, and metabolic adverse effects" (Level A). Topiramate carries a "should prescribe … when benefits outweigh risks" (Level B); botulinum toxin injections "may" be prescribed for adolescents and adults with localized bothersome simple motor tics (Level C); and deep brain stimulation is last-line — the guideline requires that multiple medication classes and behavioral therapy have been tried or are contraindicated first. The AAN also directs clinicians to assess for comorbid ADHD and OCD (Level B) and to screen for anxiety, mood and disruptive behavior disorders and to ask directly about suicidal thoughts and attempts (Level A).

Top-rated picks for tourette syndrome: 1. Clonidine Hydrochloride · 2. Onyda XR · 3. Geodon

Top-rated treatments for tourette syndrome, ranked by pharmaranks score
#DrugRatingPharmacy pays
172/100$1View →
272/100$1View →
370/100$9View →
470/100$1View →
570/100$2View →
668/100$1View →
768/100$5View →
868/100$6View →
956/100$2View →
10Not yet rated$1View →

Full ranking · 14 treatments

#1 of 10 in Central alpha-2 Adrenergic Agonist

clonidine hydrochloride

PrescriptionFDA-sourced

72/100

Clonidine Hydrochloride is a central alpha-2 adrenergic agonist used to treat Attention Deficit Disorder with Hyperactivity, Diarrhea, Dysmenorrhea, Tourette Syndrome.

(6 data points)
central alpha-2 adrenergic agonistattention deficit disorder with hyperactivitydiarrhea

Pharmacy pays

From ~$0.75/30· 8 forms Save up to 5% in class
View details →
#1 of 10 in Central alpha-2 Adrenergic Agonist

onyda xr

PrescriptionFDA-sourced

72/100

Onyda XR (Clonidine Hydrochloride) is a central alpha-2 adrenergic agonist used to treat Attention Deficit Disorder with Hyperactivity, Diarrhea, Dysmenorrhea, Tourette Syndrome.

(4 data points)
central alpha-2 adrenergic agonistattention deficit disorder with hyperactivitydiarrhea

Pharmacy pays

From ~$0.75/30· 8 forms Save up to 5% in class
View details →
VIATRIS logo
#1 of 14 in Atypical Antipsychotic

geodon

Boxed warning

PrescriptionFDA-sourced

70/100

Geodon (Ziprasidone Hydrochloride) is an atypical antipsychotic used to treat Tourette Syndrome, Schizophrenia.

(11 data points)
atypical antipsychotictourette syndromeschizophrenia

Pharmacy pays

From ~$8.21/30· 5 forms Save up to 78% in class
View details →

javadin

PrescriptionFDA-sourced

70/100

Javadin (Clonidine Hydrochloride) is a central alpha-2 adrenergic agonist used to treat Attention Deficit Disorder with Hyperactivity, Diarrhea, Dysmenorrhea, Tourette Syndrome.

(3 data points)
central alpha-2 adrenergic agonistattention deficit disorder with hyperactivitydiarrhea

Pharmacy pays

From ~$0.75/30· 8 forms Save up to 5% in class
View details →
#1 of 14 in Atypical Antipsychotic

risperdal

Boxed warning

PrescriptionFDA-sourced

70/100

Risperdal (Risperidone) is an atypical antipsychotic used to treat Autistic Disorder, Bipolar Disorder, Dementia, Tourette Syndrome.

(2 data points)
atypical antipsychoticautistic disorderbipolar disorder

Pharmacy pays

From ~$1.07/30· 8 forms
View details →

duraclon

Boxed warning

PrescriptionFDA-sourced

68/100

Duraclon (Clonidine Hydrochloride) is a central alpha-2 adrenergic agonist used to treat Attention Deficit Disorder with Hyperactivity, Diarrhea, Dysmenorrhea, Tourette Syndrome.

(16 data points)
central alpha-2 adrenergic agonistattention deficit disorder with hyperactivitydiarrhea

Pharmacy pays

From ~$0.75/30· 8 forms Save up to 5% in class
View details →

Frequently asked

What treats tourette syndrome?
Our catalog lists 14 products that may treat tourette syndrome, based on NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. They're rated where FDA recall-safety data exists; the current top-rated option is clonidine hydrochloride.
What is the best-rated treatment for tourette syndrome?
By our independent recall-safety rating — not an efficacy measure — clonidine hydrochloride ranks highest among the products we list for tourette syndrome. Always consult a professional.
How are these treatments ranked?
By our independent score, currently based on FDA regulatory recall-safety data (the methodology blends additional sources as they come online). See the How we rate page.
What types of drugs treat tourette syndrome?
Treatments for tourette syndrome span FDA drug classes including central alpha-2 adrenergic agonist, atypical antipsychotic, typical antipsychotic, phenothiazine. Compare every option side by side, ranked by independent rating, above.

Treatment associations are derived from NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. This is general reference, not medical advice — always consult a licensed professional.

Sources

The clinical overview above is written from these authoritative public-health and medical-society sources, independently reviewed against each.